Timothy T. Chole net worth and biography

Timothy Chole Biography and Net Worth

SVP & Chief Commercial Officer of Rockwell Medical

Tim Chole is Senior Vice President, Chief Commercial Officer at Rockwell Medical. Mr. Chole joined Rockwell in December 2019 as SVP, Sales and Marketing. In November 2022, following the Company's new business strategy announcement, Mr. Chole led Rockwell's commercial organization and supported the Company's vision to focus its efforts on enhancing its revenue-generating businesses and driving the Company towards profitability. Mr. Chole was promoted to Chief Commercial Officer in May 2024.

Mr. Chole has more than 20 years' experience in commercial leadership roles for pharmaceutical and medical device companies. He has a proven track record of success launching products and growing mature portfolios, many of which have been therapeutics or devices for treatment of renal disease. Early in his career, Mr. Chole served as the marketing lead for the IV iron portfolio at Watson Pharmaceuticals (now Allergan), and later was the Global Marketing Director for AKI Therapy at Gambro AB (now Baxter International Inc.). Mr. Chole's background includes global and U.S. marketing leadership and market development roles. Prior to joining Rockwell Medical, Mr. Chole served as the Director of Product Marketing and Professional Education for hearing implants at Cochlear Americas.

Mr. Chole received a Bachelor of Science degree in managerial economics from the University of California at Davis.

What is Timothy T. Chole's net worth?: The estimated net worth of Timothy T. Chole is at least $110.60 thousand as of July 1st, 2025. Mr. Chole owns 12,816 shares of Rockwell Medical stock worth more than $110,602 as of September 29th. This net worth approximation does not reflect any other investments that Mr. Chole may own. Learn More about Timothy T. Chole's net worth.
How do I contact Timothy T. Chole?: The corporate mailing address for Mr. Chole and other Rockwell Medical executives is 30142 Wixom Road, Wixom, MI, 48393. Rockwell Medical can also be reached via phone at (800) 449-3353 and via email at [email protected]. Learn More on Timothy T. Chole's contact information.
Has Timothy T. Chole been buying or selling shares of Rockwell Medical?: Timothy T. Chole has not been actively trading shares of Rockwell Medical during the last quarter. Most recently, Timothy T. Chole sold 286 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $8.20, for a transaction totalling $2,345.20. Following the completion of the sale, the senior vice president now directly owns 12,816 shares of the company's stock, valued at $105,091.20. Learn More on Timothy T. Chole's trading history.
Who are Rockwell Medical's active insiders?: Rockwell Medical's insider roster includes Timothy Chole (SVP & Chief Commercial Officer), John Cooper (Director), Heather Hunter (COO), Jesse Neri (CFO), and Mark Strobeck (President & CEO). Learn More on Rockwell Medical's active insiders.
Are insiders buying or selling shares of Rockwell Medical?: During the last year, insiders at the sold shares 2 times. They sold a total of 793 shares worth more than $7,814.30. The most recent insider tranaction occured on November, 18th when Director John G Cooper sold 507 shares worth more than $4,410.90. Insiders at Rockwell Medical own 4.6% of the company. Learn More about insider trades at Rockwell Medical.
Information on this page was last updated on 11/18/2025.

Timothy T. Chole Insider Trading History at Rockwell Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/1/2025	Sell	286	$8.20	$2,345.20	12,816
4/1/2025	Sell	286	$10.80	$3,088.80	4,603
10/1/2024	Sell	100	$36.90	$3,690.00	5,517

Timothy T. Chole Buying and Selling Activity at Rockwell Medical

Rockwell Medical Company Overview

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Today's Range

Now: $8.63

$8.26

$8.74

50 Day Range

MA: $7.67

$6.28

$8.85

2 Week Range

Now: $8.63

$4.89

$12.90

Volume

17,602 shs

Average Volume

20,941 shs

Market Capitalization

$34.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.64